Jeffrey A. Schwaneke Agilon Health, Inc. (AGL) insider trading activity

Jeffrey A. Schwaneke is Chief Financial Officer of agilon health, inc.. Currently has a direct ownership of 1.68 Million shares of AGL, which is worth approximately $971,570. The most recent transaction as insider was on Jan 10, 2026, when has been sold 600,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.68M

55.81% 3M change

131.39% 12M change

Total Value Held $971,570

Jeffrey A. Schwaneke Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 10 2026	BUY Grant, award, or other acquisition	-	600,000 Added 26.37%	1,675,122 Common Stock
Jul 01 2025	SELL Payment of exercise price or tax liability	$109,715 $2.38 p/Share	46,099 Reduced 4.11%	1,075,122 Common Stock
May 28 2025	SELL Payment of exercise price or tax liability	$21,927 $2.35 p/Share	9,331 Reduced 0.83%	1,121,221 Common Stock
Jul 01 2024	BUY Grant, award, or other acquisition	-	659,880 Added 47.69%	723,930 Common Stock
May 29 2024	BUY Grant, award, or other acquisition	-	32,119 Added 33.4%	64,050 Common Stock
Nov 29 2023	BUY Open market or private purchase	$250,206 $11.22 p/Share	22,300 Added 41.12%	31,931 Common Stock
Apr 14 2023	BUY Grant, award, or other acquisition	-	5,622 Added 36.86%	9,631 Common Stock

Aug 10 2022	BUY Grant, award, or other acquisition	-	4,009 Added 50.0%	4,009 Common Stock

Also insider at

CNC

CENTENE CORP Healthcare

EVP, HealthCare Enterprises

JAS